Aspen showing upside to R204 despite Trump pulling funds from SAOk this isn't the best formation.
We have the price above 20MA but still below 200MA.
On the other hand, we have a solid bottom formed and a W Formation along with a Box Formation with it.
So with the pull back and the retest, we could get a bounce up which will send the price to potentially R
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.53 USD
240.46 M USD
2.44 B USD
348.76 M
About Aspen Pharmacare Holdings Limited
Sector
Industry
CEO
Stephen Bradley Saad
Website
Headquarters
Durban
Founded
1850
ISIN
ZAE000066692
FIGI
BBG000DB4194
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals segment consists of the following business sub segments: Sterile Focused Brands, which includes the Anaesthetics and Thrombosis portfolios; and Regional Brands, which are products that are managed on a regional basis. The Manufacturing segment focuses on the following business sub segments: Active Pharmaceutical Ingredients, which involved in API Chemicals business and non-heparin biochemical API business; Heparin, which refers to the full value chain contribution from all heparin containing products; FDF Steriles, which includes all FDF sterile sales; and FDF Other, which consists of all non-sterile FDF products. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.
Related stocks
ASPEN nearly ready for a strong shot down to R151.06!Inv Cup and Handle has been forming on Aspen.
The price is >20 and 200 showing that the momentum is down.
I am eagerly waiting for a strong break below, before I look at getting into a long holding short (sell trade).
My first target will be at R151.06
Our opinion on the current state of ASPEN(APN)Aspen (APN) is a global pharmaceutical company that operates in 150 countries, offering a wide range of specialty and branded products designed to address various acute and chronic medical conditions. The company has 25 manufacturing facilities across 15 sites, with its primary product categories in
Aspen Seeking to Push into Weekly Cycle HighAspen is consolidating in a symmetrical triangle, it has good support in the triangle and the median line of Pitchfork. On the weekly perspective we are in time for a half cycle correction hence I expect the price to resolve upwards.
The stop-loss is R185.41
UPDATE: Target Reached Aspen R206.03 - Next target higherSymmetrical Triangle was a a text book trade. The previous trend was up. Price broke above the apex 3/4s in and the momentum continued up.
We had further indicators of confirmation for upside to come.
Price>20
Price>200
Target 1 R206.03
So what now? Well we can expect somewhat a consolidation, an
Our opinion on the current state of APNAspen Pharmacare Holdings Limited (APN), a leading pharmaceutical company, operates globally, distributing its products across 150 countries. The company's diversified product range targets various acute and chronic medical conditions, with a focus on thrombosis, anaesthetics, cytotoxics, and nutrit
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of APNHF is 7.25 USD — it has increased by 13.81% in the past 24 hours. Watch Aspen Pharmacare Holdings plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Aspen Pharmacare Holdings plc stocks are traded under the ticker APNHF.
We've gathered analysts' opinions on Aspen Pharmacare Holdings plc future price: according to them, APNHF price has a max estimate of 7.08 USD and a min estimate of 6.52 USD. Watch APNHF chart and read a more detailed Aspen Pharmacare Holdings plc stock forecast: see what analysts think of Aspen Pharmacare Holdings plc and suggest that you do with its stocks.
APNHF reached its all-time high on Jan 26, 2015 with the price of 39.00 USD, and its all-time low was 3.10 USD and was reached on Dec 15, 2008. View more price dynamics on APNHF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
APNHF stock is 12.14% volatile and has beta coefficient of 0.77. Track Aspen Pharmacare Holdings plc stock price on the chart and check out the list of the most volatile stocks — is Aspen Pharmacare Holdings plc there?
Today Aspen Pharmacare Holdings plc has the market capitalization of 2.57 B, it has increased by 1.98% over the last week.
Yes, you can track Aspen Pharmacare Holdings plc financials in yearly and quarterly reports right on TradingView.
Aspen Pharmacare Holdings plc is going to release the next earnings report on Sep 3, 2025. Keep track of upcoming events with our Earnings Calendar.
APNHF net income for the last half-year is 125.61 M USD, while the previous report showed 114.11 M USD of net income which accounts for 10.07% change. Track more Aspen Pharmacare Holdings plc financial stats to get the full picture.
Yes, APNHF dividends are paid annually. The last dividend per share was 0.20 USD. As of today, Dividend Yield (TTM)% is 3.48%. Tracking Aspen Pharmacare Holdings plc dividends might help you take more informed decisions.
Aspen Pharmacare Holdings plc dividend yield was 1.54% in 2024, and payout ratio reached 36.21%. The year before the numbers were 1.86% and 29.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 3, 2025, the company has 9.35 K employees. See our rating of the largest employees — is Aspen Pharmacare Holdings plc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aspen Pharmacare Holdings plc EBITDA is 639.30 M USD, and current EBITDA margin is 23.95%. See more stats in Aspen Pharmacare Holdings plc financial statements.
Like other stocks, APNHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aspen Pharmacare Holdings plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aspen Pharmacare Holdings plc technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aspen Pharmacare Holdings plc stock shows the sell signal. See more of Aspen Pharmacare Holdings plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.